Try The Drug Club risk-free for 30 days Trial terms

AML (IDH2-Mutant) Medication Savings with TheDrugClub

Last updated

Members can check active-formulary eligibility and membership pricing for AML (IDH2-Mutant) medications. A condition association alone does not establish coverage.

What Is AML (IDH2-Mutant)?

AML (IDH2-Mutant) is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.

Managing AML (IDH2-Mutant) with TheDrugClub

Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.

  1. Join TheDrugClub as a member
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

About AML (IDH2-Mutant)

Acute Myeloid Leukemia (AML) with an IDH2 mutation is a distinct subtype of blood cancer requiring specialized treatment. This genetic marker influences disease progression and therapeutic approaches. While targeted therapies offer new hope, the cost of these life-saving medications can be a significant burden. TheDrugClub helps individuals and families manage these expenses, ensuring access to vital prescriptions.

Acute Myeloid Leukemia (AML) is a fast-growing cancer that affects the blood and bone marrow, leading to an overproduction of abnormal white blood cells. While AML can manifest in various forms, a specific subtype, known as AML IDH2 mutant, is characterized by a mutation in the isocitrate dehydrogenase 2 (IDH2) gene. This genetic alteration is found in approximately 8-19% of AML patients and plays a crucial role in the disease's development and progression.

The IDH2 mutation leads to the production of an oncomet

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

Related conditions

Participating pharmacy savings paths

Start Your Risk-Free Trial
Start Your Risk-Free Trial